Psoriasis, COVID ‐19, and acute respiratory distress syndrome: Focusing on the risk of concomitant biological treatment-Reference-Cited by-同舟云学术

Psoriasis, COVID ‐19, and acute respiratory distress syndrome: Focusing on the risk of concomitant biological treatment

Published:2020-06-19 Issue:4 Volume:33 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Magnano Michela¹^ORCID,Balestri Riccardo¹,Bardazzi Federico²,Mazzatenta Carlo³,Girardelli Carlo R.¹,Rech Giulia¹

Affiliation:

1. Division of Dermatology Psoriasis Outpatient Service, Santa Chiara Hospital Trento Italy

2. Division of Dermatology, Department of Experimental Diagnostic and Specialty Medicine University of Bologna Bologna Italy

3. Division of Dermatology, San Luca Hospital Lucca Italy

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.13706

Reference8 articles.

1. The impact of the COVID ‐19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience

2. The viral, epidemiologic, clinical characteristics and potential therapy options for COVID‐19: a review;Li C;Eur Rev Med Pharmacol Sci,2020

3. Biologic therapy for psoriasis during the covid-19 outbreak is not a choice

4. RiccardoF AndrianouX BellaA Del MansoM UrdialesAM FabianiM et al. For Istituto Superiore di Sanità. 7th May 2020. Retrieved byhttps://www.epicentro.iss.it/coronavirus/bollettino/Bollettino‐sorveglianza‐integrata‐COVID‐19_7‐maggio‐2020.pdf(last accessed May 14 2020).

5. Evolution of topical steroids consumption before and after initiation of systemic treatment in psoriasis: epidemiologic study in a real‐world analysis of the French national health insurance database

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors associated with COVID-19 severity in patients with spondyloarthritis: Results of the French RMD COVID-19 cohort;Joint Bone Spine;2023-12

2. A systematic review and meta‐analysis of investigating the mutual impact of COVID‐19 and psoriasis: Focusing on COVID‐19 course in psoriasis and the opinion on biologics in this setting;Immunity, Inflammation and Disease;2023-11

3. Risk of COVID-19 infection, hospitalization and mortality in psoriasis patients treated with interleukin-17 inhibitors: A systematic review and meta-analysis;Frontiers in Immunology;2022-10-21

4. Systematic review with meta‐analysis: COVID‐19 outcomes in patients receiving anti‐TNF treatments;Alimentary Pharmacology & Therapeutics;2021-12-08

5. COVID-19 Vaccine Hesitancy Among Patients with Inflammatory Bowel Disease on Biologic Therapies; A cross-sectional study;2021-12-08